Travel & leisure stocks outperform following full FDA vaccine approval By Investing.com


© Reuters.

By Samuel Indyk

Investing.com – Travel and leisure stocks were outperforming in the UK on Tuesday after the US Food and Drug Administration (FDA) fully approved Pfizer (NYSE:) and BioNTech’s (NASDAQ:) Covid vaccination. It is the first jab to be fully licenced after previously receiving Emergency Use Authorization (EUA).

Full approval

Approval of the vaccine is expected to lead to greater take-up amongst US citizens. A recent survey by the Kaiser Family Foundation found that 31% of unvaccinated people said they were more likely to get vaccinated if the FDA gave full approval to vaccines, according to Bloomberg News.

Separately, many companies and organisations are expected to introduce vaccine mandates. The US military set this off, saying they would require all 1.3 million active-duty troops to get vaccinated.

Travel & Leisure shares jump

Shares in stocks jumped following the news. Cineworld (LON:) – which has operations in the US – saw its shares rally as greater vaccination take up in the US may encourage cinemagoers to return to screens. Earlier this month, Cineworld had said there could be “no certainty” over its recovery from the pandemic in the short-term as revenue declined 59% in the first half of the year.

Airlines were also strong, with EasyJet (LON:), Wizz Air (LON:), Ryanair (LON:), and IAG (LON:) all trading higher. Carnival (NYSE:) (LON:), which is dual listed in the UK and US, also reacted positively to the news. Its US listed shares closed higher by just shy of 4% on Monday, while its London listing jumped over 3% in early trade on Tuesday.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.